Covid-19 Vaccination Roll-out

Ian Paisley Excerpts
Monday 11th January 2021

(1 month, 3 weeks ago)

Westminster Hall

Read Full debate Read Hansard Text
Department for Business, Energy and Industrial Strategy
David Amess Portrait Sir David Amess (in the Chair)
- Hansard - - - Excerpts

The debate finishes at 7.30 pm. Five colleagues wish to speak, and I want to call all of them, so I suggest that everyone speak for about five minutes. That will give the Minister and his opposite number time to respond to the debate.

Ian Paisley Portrait Ian Paisley (North Antrim) (DUP)
- Hansard - -

It is an honour to serve under your chairmanship, Sir David. I will apologise at this point, because I am listed as No. 11 in the main Chamber afterwards and I want to get to the Global UK debate—not the Global Britain debate, because I live in the UK; but that is a separate point. As we say at home, it would starve you in here. It is so cold that I think Pfizer could use this room to keep its vaccine at the proper temperature for us all.

It is an honour to follow my colleague the hon. Member for Winchester (Steve Brine), who quite rightly said that he has been disappointed so far with 2021. I have finished my 10-day free trial and I want a refund on the rest of 2021. Look, it is absolutely, entirely a matter of free will whether someone takes a vaccine if and when it becomes available. I am delighted that people are being given so much encouragement to take the vaccine. Of course, that has to be mixed with support for testing people and making sure that the right people get the vaccine as quickly as possible. It is absolutely right and proper that those most at risk are at the head of the queue.

I welcome the fact that today the Northern Ireland Executive have prioritised domiciliary care staff receiving the vaccine in Northern Ireland. That started this afternoon. Quite frankly, there is a hierarchy of frontline workers. The hon. Member for Gower (Tonia Antoniazzi) was right to point out that educationalists should be at the top of that list, because of their reach across the entire community, whether they are early years workers or schoolteachers, or they manage kids with special needs in schools and institutions that have not been closed down as a result of covid. It is important that those frontline workers do not feel that they are second or third in the queue, and that society recognises their key and important role. It is disappointing to read that in some hospitals, more management staff have received the vaccine than nursing staff. That is abhorrent and wrong, and that balance has to be addressed. It is important that our frontline workers—our nursing staff—get it.

I strongly believe that schoolteachers are on the frontline. If we want schools to open again quickly, we have to start with early years and go right the way through to make sure that children can get back to school for the sake of their mental health, of opening up our society again and, of course, of promoting the welfare of our young people.

Tonia Antoniazzi Portrait Tonia Antoniazzi
- Hansard - - - Excerpts

The hon. Gentleman brought up mental health, which is really important. I am greatly concerned about my 16-year-old studying for his A-levels. He has just started college with a new group of friends, but he does not have the opportunity to socialise and have the life experiences that we experienced. Does the hon. Gentleman agree that it is of utmost importance to get children and students back into school and education as soon as possible?

Ian Paisley Portrait Ian Paisley
- Hansard - -

The hon. Member has knocked it out of the park; she is absolutely right. It is key that we get our kids back in there so that they can socialise and work together again, and be the engine room of our society for the future. That will only happen when we get them back to school and facilitate that.

I received an email today from Ben Sidor, a student at Queen’s University Belfast. It is not just at the school level, but at the university level that people are being denied the positive interactions with their friends and peers that will allow them to become the men and women of tomorrow that society will look up to generation after generation. We must encourage that.

The hon. Member for Winchester mentioned the use of other organisations, which is important. Community pharmacies are key to the roll-out of the vaccine. Frankly, community pharmacists in my constituency have saved the NHS in the last couple of years. They are undervalued and underrated, yet they play a key role. Getting pharmacists on to the frontline to help with the roll-out is critical.

I also welcome the call to use the skills of our military. The Army is brilliant at logistical planning. We should use its skill to roll out the plan and to make sure that it is quick, efficient and agile, and that it responds to the needs of the community on the ground. There is no reason why our Army could not be used for that positive work. We are quite happy to send it to Sierra Leone to roll out vaccination projects there, so why can we not do that in our own nation and use its logistical planning skills?

I fear that there will be a shortage that will have an impact on certain parts of the United Kingdom. The Northern Ireland protocol already means that PPE is waiting at Stranraer and cannot get into Northern Ireland because of tax inspectors. Can you imagine, Sir David, if the same happened with vaccinations—if they were ready for Northern Ireland, but could not get there because of the protocol? That needs to be addressed urgently, and I raised the point personally with the Chancellor today.

I leave hon. Members with those thoughts. I welcome the debate, which is very important. I hope that those who wish, of their free will, to have the vaccination have that facilitated urgently.

Stephen Doughty Portrait Stephen Doughty (Cardiff South and Penarth) (Lab/Co-op)
- Hansard - - - Excerpts

It is always a pleasure to serve under your chairmanship, Sir David. I thank my hon. Friend the Member for Gower (Tonia Antoniazzi) for her introduction to the debate.

I declare an interest: my partner is a teacher who has been dealing with covid-safe procedures in school, and has dealt with many Track and Trace processes, so I have heard about the challenges in our schools very clearly. I have also heard from those in retail. I have close associations with the Union of Shop, Distributive and Allied Workers; I declare that interest, too. It is really important that we listen to all those concerns, because there is deep worry in the country about the case rates. In particular, I have heard concerns relating to special schools and the care that they provide; that was mentioned earlier. I have Ysgol Y Deri in my constituency, a fantastic school that is part of the Penarth Learning Community. The First Minister in Wales has been very clear that we will extend vaccination to staff working in those contexts, given the care that they provide to often vulnerable young people. That is good to hear.

I commend the Welsh Government on the vaccination strategy set out today by my constituency colleague, the Welsh Minister for Health and Social Services, Vaughan Gething; I know the Minister here also set one out today. It is important that we get information on those strategies out there, because we are hearing a lot of worry and genuine concern. Of course, everybody wants to be vaccinated, including those in frontline work and those who are particularly vulnerable. That is why it is absolutely crucial that we secure the supply and production.

I praise the work of my local health board, Cardiff and Vale University Health Board, which in recent days has rapidly scaled up its vaccination plans and the number of vaccinations it has delivered. I spoke to members of its staff this morning. A few days ago, when I visited my GP on a personal matter, I was pleased to hear that the member of staff treating me had been vaccinated, and was looking forward to being part of the roll-out programme that the Health Minister in Wales set out today, in which an increasing number of GPs will be involved. Community pharmacies, which have been mentioned, will be involved too. They have a critical role. I am pleased that it was set out today that they are part of the plan in Wales. I hope they will be part of the plan across the whole UK.

The reality we face, as shown in the petition, is that there are very difficult choices of prioritisation. I think everyone recognises that, including many of those who have contacted me to ask, “When am I going to get the vaccination?” It is really important that we follow the best scientific, medical and clinical evidence set out by the Joint Committee on Vaccination and Immunisation and others. I want assurances that the Minister is considering all the representations that are being made, because it is important that there should be confidence in the difficult decisions that are reached. For example, there has been a lot of anxiety about spreading out the dosing. I have heard concerns from health professionals about that, and I appreciate that there is a live debate on that. We need confidence in all these choices, and in the decisions taken at UK level by the Medicines and Healthcare products Regulatory Agency, the JCVI and jointly by chief medical officers. I have a huge amount of respect and admiration for them; they are having to make difficult choices because we do not have enough supply in the country.

That is the point I largely want to deal with. I have already raised a number of issues on that subject with the Minister. I would like clearer guarantees on the schedule for delivery to and around the UK. My constituents in Wales want to know when vaccine procured for the UK is being delivered to Wales, and when the different types of vaccine are being delivered to Wales. We know about the Oxford-AstraZeneca and Pfizer-BioNTech vaccines; when will the Moderna vaccine first be delivered to this country, and how will it be rolled out? I have heard positive things about a Johnson & Johnson vaccine; when do we think that will be approved by the MHRA, and when might we see supplies?

First, I would like more assurances from the Minister about our productive capacity in the UK. We all know that things can go wrong; there could be problems with delivery, accidental damage or contamination. Any of those things could happen. How are we scaling up our productive capacity in the UK to create all the different types of vaccines? What new factories are being built? What new facilities are being procured? That is right down to the level of capital equipment available in this country for vaccine production.

Secondly, the other crucial part of the process is the cold chain. We know that there have been issues with, for example, the Pfizer-BioNTech vaccine and the way in which it has to be kept at that hyper-low temperature. Will that be similar for some of the other RNA vaccines? If so, what are we doing to scale up our cold chain and storage capacity to enable such vaccines to be used more quickly across the country? As we know, the Oxford-AstraZeneca one can be kept in a fridge, but that of course still requires a safe cold chain to get it to all the key locations.

Thirdly, the fill and finish part of the production process is critical. The Minister knows that I have asked him questions about the Wockhardt factory in north Wales. What other fill and finish capacity do we have across the UK? Will he be specific about that? What are we doing to expand it? I want to see those plants operating 24 hours a day, seven days a week, with the supplies coming in all the time, getting into those phials and getting out to our communities across the country. Fundamentally, that is a UK responsibility and the responsibility of the Minister. I hope that he can give us some assurances on that.

Lastly, at the moment there is rightly a lot of concern about variants. At some point in the future, obviously, we will have to produce tweaked vaccine alternatives to deal with variants that may emerge, in the way that we do with the flu vaccine. Will the Minister give us assurances on how our productive capacity will be there to produce variant vaccines at the right moment, when we need them in the future? We need to get through this first phase, absolutely, but we also have to look at the medium and long term, because this virus is not going away anytime soon.